483 Allergan Sales May 2003

483 Allergan Sales May 2003

David Beltran FDA, Daniel Lahar FDA$595.00 - Available Now

FDA investigators audited the Allergan Sales - Waco, TX, United States facility and issued inspectional observations (via FDA 483) on 14 May 2003.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 14 May 2003
  • Location: Waco, United States
  • FEI: 1643525
Add To Cart